BRCA1 and cancer: Therefore, to identify the differences between BRCA1/2-MUT BC and BRCA1/2 wild-type (BRCA1/2-WT) BC, we used consensus WGCNA, an improved analysis method which was conducted in our study using a slightly different R package code on the basis of the general principles of WGCNA, thereby perform the comparison of the effect of modules on associated clinical traits between mutant and WT cancers.